 WATERTOWN, Mass.--BUSINESS WIRE--Enanta Pharmaceuticals, Inc. NASDAQ:ENTA, a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, will participate in two fireside chats being webcast in June: Jefferies Healthcare Conference: Fireside Chat at 9:00 a.m. ET on June 9, 2022 JMP Securities Life Sciences Conference: Fireside Chat at 9:30 a.m. ET on Ju 